MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

12 Nov 2022 Evaluate
The Total revenue for the quarter ended September 2022 of  Rs. 30256.60 millions remain, more or less, the same.The Net Profit of the company registered a slight decline of -16.72% to Rs. 1646.30  millions from Rs. 1976.80 millions.The company reported a degrowth in operating Profit to 3517.60 millions from 4221.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 30256.60 28831.80 4.94 58125.80 57769.30 0.62 112871.40 158236.80 -28.67
Other Income 558.60 823.70 -32.18 945.70 1263.20 -25.13 6709.90 5898.60 13.75
PBIDT 3517.60 4221.00 -16.66 6327.30 8768.60 -27.84 21443.90 47096.90 -54.47
Interest 192.00 34.40 458.14 270.50 85.00 218.24 169.40 286.80 -40.93
PBDT 3325.60 4186.60 -20.57 6056.80 8683.60 -30.25 20527.40 46810.10 -56.15
Depreciation 1088.00 981.80 10.82 2118.50 2128.30 -0.46 4152.60 4880.00 -14.91
PBT 2237.60 3204.80 -30.18 3938.30 6555.30 -39.92 16374.80 41930.10 -60.95
TAX 591.30 1228.00 -51.85 1070.40 2427.80 -55.91 1827.70 10801.00 -83.08
Deferred Tax -30.00 7.60 -494.74 -119.90 -227.00 -47.18 -1969.30 367.60 -635.72
PAT 1646.30 1976.80 -16.72 2867.90 4127.50 -30.52 14547.10 31129.10 -53.27
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 11.63 14.64 -20.59 10.89 15.18 -28.28 19.00 29.76 -36.17
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..